MedXY – Page 4 – Medxy AI

Polygenic Risk Impact on Lifetime Risk and Prognosis of Glaucoma: Clinical Insights and Future Applications

By MedXY 11/07/2026

This review synthesizes recent evidence demonstrating that glaucoma polygenic risk scores (PRS) enhance risk stratification and prognosis, outperforming family history, and supporting PRS-guided screening and management interventions.

Clinical Updates Diabetes & Endocrinology General Surgery

Preserving Parathyroid Function: Comparing Postoperative Hypocalcemia in Total Versus Completion Thyroidectomy

By MedXY 11/07/2026

Completion thyroidectomy performed after an interval shows superior parathyroid preservation and lower postoperative hypocalcemia risk compared to initial total thyroidectomy, supporting a staged surgical approach for optimized safety.

Clinical Updates OB/GYN & Women's Health Urology

Noninferiority of Periurethral vs Intravaginal Estrogen Application in Preventing Recurrent Urinary Tract Infections in Postmenopausal Women

By MedXY 11/07/2026

This randomized trial demonstrates that periurethral estradiol cream application is noninferior to intravaginal application for preventing recurrent urinary tract infections in postmenopausal individuals, with comparable efficacy and improved local tolerability.

Clinical Updates Gastroenterology Nephrology

Intravenous Albumin Post-Outpatient Paracentesis Lowers AKI Hospitalization Risk in Cirrhosis: Insights from a National Cohort Study

By MedXY 11/07/2026

This national cohort study reveals that intravenous albumin administration after outpatient paracentesis significantly reduces hospitalization rates for acute kidney injury, especially in cirrhotic patients with impaired renal function.

Cenobamateは局在発作型の難治性・超難治性重積発作に有効か ― 多施設コホート研究とマッチ解析

Clinical Updates Critical Care Neurology

Cenobamate in Focal-Onset Refractory and Super-Refractory Status Epilepticus: A Multicenter Cohort Study With Matched Analysis

By MedXY 11/07/2026

This multicenter study shows cenobamate is effective and safe as adjunctive therapy for refractory focal-onset status epilepticus, improving seizure control and outcomes.

Clinical Updates Diabetes & Endocrinology

Efficacy and Safety of Oral Orforglipron in Japanese Adults with Obesity Disease: Insights from the ATTAIN-J Phase 3 Trial

By MedXY 11/07/2026

The ATTAIN-J trial demonstrated that once-daily oral orforglipron significantly reduced bodyweight with a favorable safety profile in Japanese adults with obesity disease, aligning with global findings on GLP-1 receptor agonists.

Cardiology Clinical Updates

Transcatheter Aortic Valve Replacement in Severe Pure Aortic Regurgitation: Insights from the SEASON-AR Randomized Trial

By MedXY 11/07/2026

This article reviews the SEASON-AR trial demonstrating that TAVR plus medical therapy significantly reduces death, disabling stroke, and heart failure rehospitalization at one year compared to medical therapy alone in high-risk patients with severe pure aortic regurgitation.

Clinical Updates Oncology Urology

FGFR Alterations in Bladder Cancer: From Molecular Pathogenesis to Precision Oncology

By MedXY 11/07/2026

FGFR alterations, especially in FGFR3 and FGFR2, are pivotal biomarkers in urothelial carcinoma, advancing personalized diagnosis, treatment, and monitoring across disease stages. Emerging molecular diagnostics and targeted therapies promise improved patient outcomes.

Cardiology Clinical Updates Respiratory

Unlocking the Variability in Cardiopulmonary Exercise Testing: Impact of Prediction Equations on Exercise Capacity Classification

By MedXY 11/07/2026

Different cardiopulmonary exercise testing prediction equations yield widely variable percent-predicted values for peak oxygen uptake, leading to frequent reclassification of exercise performance influenced mainly by body mass index, age, and sex.

Clinical Updates Plastic Surgery Psychiatry

Persistent Pain and Pruritus in Burn Survivors: Long-Term Outcomes and PTSD as a Key Predictor

By MedXY 11/07/2026

This prospective multicenter study highlights the persistence of chronic pain and pruritus up to one year after burn injury and identifies PTSD symptoms as a significant risk factor, underscoring the need for integrated psychosomatic rehabilitation.

Clinical Updates Dentistry Infectious Diseases Neurology

Porphyromonas gingivalis-Induced NETs: A Bridge Between Periodontitis and Alzheimer’s Disease via TLR4 Activation

By MedXY 11/07/2026

This study elucidates how Porphyromonas gingivalis-induced neutrophil extracellular traps (NETs) contribute to neuroinflammation and cognitive impairment through TLR4 activation, revealing a mechanistic link between periodontitis and Alzheimer's disease progression.

不明原因不孕中 IVF 与 IUI 的比较：多中心随机对照试验中的疗效与安全性评估

Clinical Updates OB/GYN & Women's Health

IVF versus IUI in Unexplained Infertility: Evaluating Efficacy and Safety in a Multicenter RCT

By MedXY 11/07/2026

A landmark multicenter randomized trial reveals that first-line IVF yields higher live-birth rates than IUI with ovarian stimulation in unexplained infertility, with cumulative outcomes equalized after subsequent cycles.

Clinical Updates Gastroenterology Internal Medicine

Advancing Diagnosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from the LITMUS Multicentre Study

By MedXY 11/06/2026

The LITMUS study evaluates non-invasive biomarkers for diagnosing metabolic dysfunction-associated steatotic liver disease, highlighting proteomic panels' promise in detecting at-risk steatohepatitis and fibrosis stages, potentially replacing biopsy.

Clinical Updates Critical Care Pediatrics

Reducing Post-PICU Acute Care through Early Primary Care Follow-Up: Evidence from Pediatric Hospitalizations

By MedXY 11/06/2026

Early primary care follow-up within 7 days after pediatric ICU discharge is significantly associated with reduced acute care use, including emergency visits and rehospitalizations, highlighting a critical opportunity to improve post-critical illness outcomes in children.

Clinical Updates Dermatology Rheumatology

Targeting IL-4 Receptor-α in Localised Scleroderma: Promising Phase 2 Evidence for Fibrosis Modulation

By MedXY 11/06/2026

This phase 2 randomized trial demonstrates that IL-4-receptor-α blockade with dupilumab significantly improves clinical outcomes and reduces fibrosis-associated inflammation and gene signatures in localised scleroderma, supporting a novel therapeutic strategy for fibrosing diseases.

Clinical Updates OB/GYN & Women's Health Transplantation

Optimizing Outcomes in Uterus Transplantation: Comprehensive Living Donor Evaluation from the Dallas Program

By MedXY 11/06/2026

This article reviews the Dallas Uterus Transplant Program's rigorous living donor evaluation process, highlighting its critical role in optimizing donor safety and recipient success in uterus transplantation.

Clinical Updates Dermatology Rheumatology

Decoding Systemic Sclerosis: A New Vascular-Fibrotic Framework for Risk Stratification

By MedXY 11/06/2026

This study introduces a novel classification framework for systemic sclerosis based on vascular and fibrotic complications, identifying a high-risk mixed endotype with distinct immunologic features and prognostic relevance, offering improved personalized management potential.

Clinical Updates Plastic Surgery

Enhancing Surgical Timing in Tissue Expansion with 3D Scanning-Based Predictive Modeling

By MedXY 11/06/2026

A novel three-dimensional scanning workflow accurately predicts tissue expansion progress, optimizing surgical timing and improving reconstructive outcomes for congenital melanocytic nevus patients.

正念导向康复增强如何重塑阿片类物质使用障碍的前额叶皮层：来自随机对照试验的神经生物学与临床启示

Clinical Updates Psychiatry

Prefrontal Cortical Remodeling via Mindfulness-Oriented Recovery Enhancement in Opioid Use Disorder: Neurobiological and Clinical Insights from a Randomized Controlled Trial

By MedXY 11/06/2026

Mindfulness-Oriented Recovery Enhancement (MORE) modulates prefrontal cortical activity, reduces craving, and prolongs abstinence in opioid use disorder by rebalancing neural responses to drug and natural rewards, substantiating its role as an adjunct to pharmacotherapy.

Clinical Updates Critical Care Infectious Diseases

Timely Antifungal Therapy Initiation Is Crucial in Improving Outcomes in Candida Septic Shock

By MedXY 11/06/2026

Delayed appropriate antifungal therapy after the onset of persistent hypotension dramatically increases mortality in Candida septic shock; survival drastically improves with treatment within 2 hours.